Search hospitals > Florida > Miami
Veterans Affairs Medical Center -Washington DC
Claim this profileMiami, Florida 33125
Global Leader in Lung Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Head and Neck Cancers
Conducts research for Lymphoma
Conducts research for Neck Cancer
212 reported clinical trials
12 medical researchers
Summary
Veterans Affairs Medical Center -Washington DC is a medical facility located in Miami, Florida. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Head and Neck Cancers, Lymphoma, Neck Cancer and other specialties. Veterans Affairs Medical Center -Washington DC is involved with conducting 212 clinical trials across 348 conditions. There are 12 research doctors associated with this hospital, such as George Kurdgelashvili, MD, Jared M. Gollie, PhD, Anita Aggarwal, and Debra Benator, MD.Area of expertise
1Lung Cancer
Global LeaderStage III
Stage IV
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
George Kurdgelashvili, MDOklahoma City VA Medical Center, Oklahoma City, OK7 years of reported clinical research
Studies Osteomyelitis
Studies Diabetes
2 reported clinical trials
4 drugs studied
Jared M. Gollie, PhDWashington DC VA Medical Center, Washington, DC1 year of reported clinical research
Studies Contrast-induced Nephropathy
Studies Chronic Kidney Disease
2 reported clinical trials
2 drugs studied
Anita AggarwalWashington DC VAMC2 years of reported clinical research
Studies Pulmonary Embolism
Studies Thrombus
2 reported clinical trials
3 drugs studied
Debra Benator, MDVeterans Affairs Medical Center2 years of reported clinical research
Studies Diffuse Large B-Cell Lymphoma
Studies HIV Infection
2 reported clinical trials
2 drugs studied
Clinical Trials running at Veterans Affairs Medical Center -Washington DC
Deep Vein Thrombosis
Pulmonary Embolism
Prostatic Neoplasm
Prostate Cancer
Implant Site Thrombosis
Termination of Pregnancy
Thromboembolic Disease
Venous Thromboembolism
Central Venous Access Device Thrombosis
Kidney Disorders
Abelacimab vs Dalteparin
for Blood Clot Prevention in Cancer Patients
This trial compares a new medication, Abelacimab, to another treatment, Dalteparin, in patients with GI or GU cancer who have had blood clots. The goal is to see which treatment better prevents new clots and reduces bleeding risks.
Recruiting2 awards Phase 35 criteria
Abelacimab vs Apixaban
for Cancer-Related Blood Clots
This trial is testing abelacimab, a medication, to prevent blood clots in cancer patients who have had previous clots. It aims to see if it works better and causes fewer bleeding problems compared to a current treatment.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Veterans Affairs Medical Center -Washington DC?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.